Certain genetic loci are likely associated with late-onset psoriasis, based on data from a study of 543 cases and 4,373 healthy controls. Previous stu... More »
Specific haplotypes of the of the HLA-DRB1 gene – well known to confer increased risk for rheumatoid arthritis – proved to be strong, independent ... More »
Rheumatoid arthritis patients with low disease activity are less likely to flare if they continue their treatment with etanercept and methotrexate, ev... More »
Rheumatoid arthritis (RA) patients’ severity of morning stiffness and morning pain have stronger correlations with their disease’s activity than d... More »
T cells are still the most accurate urinary biomarker for lupus nephritis, reported Katharina Kopetschke and her coauthors.
In a study of 123 lupus p... More »
Medicare Part D recipients with rheumatoid arthritis face an average of over $2,700 per year in out-of-pocket expenses for biologic disease-modifying ... More »
SAN FRANCISCO – Apremilast met its primary endpoint at week 32 with no new or serious safety signals among patients with moderate to severe plaque p... More »
HOUSTON – For rituximab patients undergoing desensitization, mast cell degranulation is a more effective predictor of hypersensitive reactions (HSR)... More »
For patients with rheumatoid arthritis taking oral calcium supplements, higher levels of calcium in the bloodstream were not associated with an increa... More »
Disease-modifying therapy may significantly reduce rates of disability-worsening events in patients with clinically isolated syndrome and early multip... More »